Literature DB >> 21747217

Speech impairment in primary hypothyroidism.

A Mohammadzadeh1, E Heydari, F Azizi.   

Abstract

OBJECTIVE: Thyroid hormone deficiency may affect human speech and voice. The aim of this study was to evaluate speech variables in patients with hypothyroidism.
DESIGN: A case control study. PATIENTS: One hundred and twenty patients, 106 women and 14 men with symptoms and signs of thyroid failure; the diagnosis was confirmed by serum T4<4.5 μg/dl and serum TSH>10 mU/l. Eighty-eight normal subjects, 78 women and 10 men, age-, sex-, and smoking status- matched, served as controls. MEASUREMENTS: All symptoms and signs of hypothyroidism were recorded. Serum T4, T3, and TSH concentrations were measured. Speech parameters were analyzed by the Visipitch III system model 3900 and multidimensional voice program software and compared to a group of normal subjects with no thyroid disease.
RESULTS: Mean age was 35.9±11.4 yr. Dryness in larynx and pharynx, dyspnea, and sensation of lump in the throat were reported by 53.49 and 43% of patients, respectively. Fundamental frequency, voice turbulence index, and soft phonation index were significantly different from control values. There was positive correlation between TSH concentration and variation in fundamental frequency and prevalence of voice disorders (37.2±31.2 vs 23.9±25.8 mU/l, p<0.003).
CONCLUSION: Frequent speech disturbances occur in patients with primary hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21747217     DOI: 10.1007/BF03346708

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Pharyngeal and laryngeal symptoms of thyroid origin.

Authors:  R T BARTON
Journal:  N Engl J Med       Date:  1951-03-15       Impact factor: 91.245

2.  Neurodevelopment in infants and preschool children with congenital hypothyroidism: etiological and treatment factors affecting outcome.

Authors:  J F Rovet; R M Ehrlich; D L Sorbara
Journal:  J Pediatr Psychol       Date:  1992-04

3.  Nasal, pharyngeal, and laryngeal manifestations of hypothyroidism.

Authors:  O P Gupta; P L Bhatia; M K Agarwal; M L Mehrotra; S K Mishr
Journal:  Ear Nose Throat J       Date:  1977-09       Impact factor: 1.697

4.  Mild hypothyroidism and its effects on the larynx.

Authors:  P G Bicknell
Journal:  J Laryngol Otol       Date:  1973-02       Impact factor: 1.469

5.  [Hypothyroidism: clinical and etiological aspects in Cotonou (Republic of Benin)].

Authors:  F Djrolo; F Houngbé; V Attolou; B Hountondji; K Quenum; A Hountondji
Journal:  Sante       Date:  2001 Oct-Dec

6.  Dysarthria as the leading symptom of hypothyroidism.

Authors:  C Stöllberger; J Finsterer; E Brand; D Tschabitscher
Journal:  Am J Otolaryngol       Date:  2001 Jan-Feb       Impact factor: 1.808

7.  Impairment of neuromotor and cognitive development in iodine-deficient schoolchildren with normal physical growth.

Authors:  F Azizi; A Sarshar; M Nafarabadi; A Ghazi; M Kimiagar; S Noohi; N Rahbar; A Bahrami; S Kalantari
Journal:  Acta Endocrinol (Copenh)       Date:  1993-12

8.  A retrospective study on hypothyroid patients.

Authors:  E N Barton; D Kelly; E Y Morrison
Journal:  West Indian Med J       Date:  1991-03       Impact factor: 0.171

9.  Subtle speech and motor deficits of children with congenital hypothyroid treated early.

Authors:  B Gottschalk; R A Richman; L Lewandowski
Journal:  Dev Med Child Neurol       Date:  1994-03       Impact factor: 5.449

10.  The prevalence of childhood dysphonia: a cross-sectional study.

Authors:  Paul N Carding; Sue Roulstone; Kate Northstone
Journal:  J Voice       Date:  2005-12-19       Impact factor: 2.009

View more
  2 in total

1.  Voice Characteristics in Patients with Thyroid Disorders.

Authors:  Lejla Junuzović-Žunić; Amela Ibrahimagić; Selma Altumbabić
Journal:  Eurasian J Med       Date:  2019-06

Review 2.  Voice changes in reproductive disorders, thyroid disorders and diabetes: a review.

Authors:  Ewa Stogowska; Karol Adam Kamiński; Bartosz Ziółko; Irina Kowalska
Journal:  Endocr Connect       Date:  2022-03-15       Impact factor: 3.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.